FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to pharmaceutics. First invention represents a conjugate ligand-cytotoxic drug with structure formula
.
EFFECT: group of inventions includes a method for producing said conjugate, comprising a pharmaceutical composition thereof, use of said conjugate or composition for preparing a medicament for treating cancer, a method for modulating a receptor in vitro and a method of treating cancer.
32 cl, 12 ex, 4 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
LIGAND CONJUGATE WITH CYTOTOXIC DRUG PREPARATION, METHOD AND APPLICATION THEREOF | 2016 |
|
RU2708461C2 |
LIGAND-DRUG CONJUGATE OF EXATECAN ANALOGUE, ITS PRODUCTION METHOD AND ITS USE | 2019 |
|
RU2793316C2 |
ANTIBODY TO B7H3-EXATECAN ANALOGUE CONJUGATE AND ITS USE IN MEDICINE | 2019 |
|
RU2785664C2 |
CONJUGATE OF ANTI-CLAUDIN ANTIBODY AND MEDICINAL AGENT AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2826119C1 |
DERIVATIVES OF PYRROLOPYRIMIDINE USEFUL AS JAK-KINASES INHIBITORS | 2012 |
|
RU2618673C2 |
PYRAZOLOPYRIMIDONE OR PYRROLOTRIAZONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATIONS THEREOF | 2014 |
|
RU2674977C2 |
PYRIDYL KETONE DERIVATIVES, METHOD OF PREPARING SAME AND PHARMACEUTICAL APPLICATION THEREOF | 2014 |
|
RU2667892C2 |
PYRIDINE CARBOXAMIDE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2015 |
|
RU2694899C2 |
OXOTHIOIMIDAZOLINE DERIVATIVES, METHODS FOR THEIR PRODUCTION AND APPLICATION IN MEDICINE AS ANDROGEN RECEPTOR INHIBITORS | 2013 |
|
RU2639145C2 |
LINKER FOR ANTIBODY-DRUG CONJUGATES AND THEIR USE | 2019 |
|
RU2792201C2 |
Authors
Dates
2019-04-23—Published
2015-01-22—Filed